At the state of the art, in the absence of specific pharmacological therapies available, some nutraceuticals could play an important role in improving the NAFLD frameworks in association with diet and lifestyle based on weight loss and the reduction of insulin resistance. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.